These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

623 related articles for article (PubMed ID: 22084578)

  • 1. Kynurenine pathway metabolites in humans: disease and healthy States.
    Chen Y; Guillemin GJ
    Int J Tryptophan Res; 2009; 2():1-19. PubMed ID: 22084578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse.
    Saito K; Markey SP; Heyes MP
    Neuroscience; 1992 Nov; 51(1):25-39. PubMed ID: 1465184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease.
    Heyes MP; Saito K; Crowley JS; Davis LE; Demitrack MA; Der M; Dilling LA; Elia J; Kruesi MJ; Lackner A
    Brain; 1992 Oct; 115 ( Pt 5)():1249-73. PubMed ID: 1422788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and beta 2-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients.
    Heyes MP; Brew BJ; Saito K; Quearry BJ; Price RW; Lee K; Bhalla RB; Der M; Markey SP
    J Neuroimmunol; 1992 Sep; 40(1):71-80. PubMed ID: 1387655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tryptophan metabolism in the central nervous system: medical implications.
    Ruddick JP; Evans AK; Nutt DJ; Lightman SL; Rook GA; Lowry CA
    Expert Rev Mol Med; 2006 Aug; 8(20):1-27. PubMed ID: 16942634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tryptophan metabolites and brain disorders.
    Stone TW; Mackay GM; Forrest CM; Clark CJ; Darlington LG
    Clin Chem Lab Med; 2003 Jul; 41(7):852-9. PubMed ID: 12940508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The kynurenine pathway in neurodegenerative diseases: mechanistic and therapeutic considerations.
    Tan L; Yu JT; Tan L
    J Neurol Sci; 2012 Dec; 323(1-2):1-8. PubMed ID: 22939820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changing the face of kynurenines and neurotoxicity: therapeutic considerations.
    Bohár Z; Toldi J; Fülöp F; Vécsei L
    Int J Mol Sci; 2015 Apr; 16(5):9772-93. PubMed ID: 25938971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases.
    Lovelace MD; Varney B; Sundaram G; Lennon MJ; Lim CK; Jacobs K; Guillemin GJ; Brew BJ
    Neuropharmacology; 2017 Jan; 112(Pt B):373-388. PubMed ID: 26995730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain Aging and Disorders of the Central Nervous System: Kynurenines and Drug Metabolism.
    Török N; Majláth Z; Fülöp F; Toldi J; Vécsei L
    Curr Drug Metab; 2016; 17(5):412-29. PubMed ID: 26694727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesis.
    Myint AM; Kim YK
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():304-13. PubMed ID: 24184687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.
    Heyes MP; Saito K; Major EO; Milstien S; Markey SP; Vickers JH
    Brain; 1993 Dec; 116 ( Pt 6)():1425-50. PubMed ID: 8293279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The kynurenine pathway activities in a sub-Saharan HIV/AIDS population.
    Bipath P; Levay PF; Viljoen M
    BMC Infect Dis; 2015 Aug; 15():346. PubMed ID: 26285873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Kynurenines in pathogenesis of endogenous psychiatric disorders].
    Shilov IuE; Bezrukov MV
    Vestn Ross Akad Med Nauk; 2013; (1):35-41. PubMed ID: 23805637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of chromatographic methods for bioactive tryptophan metabolites, kynurenine, kynurenic acid, quinolinic acid, and others, in biological fluids.
    Fukushima T; Umino M; Sakamoto T; Onozato M
    Biomed Chromatogr; 2022 May; 36(5):e5308. PubMed ID: 34978092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of the role of vitamins and minerals on the kynurenine pathway in health and disease.
    Majewski M; Kozlowska A; Thoene M; Lepiarczyk E; Grzegorzewski WJ
    J Physiol Pharmacol; 2016 Feb; 67(1):3-19. PubMed ID: 27010891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum concentrations of kynurenines in adult patients with attention-deficit hyperactivity disorder (ADHD): a case-control study.
    Aarsland TI; Landaas ET; Hegvik TA; Ulvik A; Halmøy A; Ueland PM; Haavik J
    Behav Brain Funct; 2015 Nov; 11(1):36. PubMed ID: 26542774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal associations of macronutrient and micronutrient intake with plasma kynurenines in colorectal cancer survivors up to 12 months posttreatment.
    Holthuijsen DDB; van Roekel EH; Bours MJL; Ueland PM; Breukink SO; Janssen-Heijnen MLG; Keulen ETP; Gsur A; Kok DE; Ulvik A; Weijenberg MP; Eussen SJPM
    Am J Clin Nutr; 2023 Nov; 118(5):865-880. PubMed ID: 37923499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indoleamine 2,3 Dioxygenase as a Potential Therapeutic Target in Huntington's Disease.
    Mazarei G; Leavitt BR
    J Huntingtons Dis; 2015; 4(2):109-18. PubMed ID: 26397892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Kynurenine Pathway as a Potential Target for Neuropathic Pain Therapy Design: From Basic Research to Clinical Perspectives.
    Ciapała K; Mika J; Rojewska E
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.